Researchers from Australia's University of Queensland (UQ) and University of Cambridge in the UK have developed a platfo...
MTPConnect, Australia’s Life Sciences Innovation Accelerator, and Wholesale Investor, a leading private capi...
Australia's Monash University has announced the establishment of the Monash Boston Hub located in Boston, US. The Hub is...
Australia-based Cell Therapies and Japan's Teijin Limited have signed a Memorandum of Understanding ...
Australia’s biotech capital, Melbourne, has further strengthened its research and development capabilities through...
Starpharma, an Australian biotechnology company, has announced the signing of a collaboration and license agreement with...
BCAL Diagnostics has entered into an exclusive licence agreement with ClearNote Health Inc., a US-based precision diagno...
Australia's CSL Limited has entered into an agreement with privately held Dutch biotech company, VarmX BV, to develop a ...
The Australian Government has awarded $6 million to two Centres of Research Excellence (CREs) led by the University of S...
Engineering researchers at the University of Queensland (UQ), in Australia, are developing a low-cost tool that could di...
New South Wales' (NSW) capability for robotic, artificial intelligence (AI), digital and remote healthcare has received ...
Australia's University of Sydney has unveiled a $9 million partnership with Siemens Healthineers centred on the opening ...
Canada based PharmAla Biotech Holdings Inc., a biotechnology company focused on the research, development, and manu...
xCystence Bio, a Monash University biotech company, has secured a top-up funding boost from Brandon BioCatalyst’s ...
Australian children will now have stronger protection against pneumococcal with the Australian Government implementing a...
What are the major highlights at Invion Group in 2025? Are you planning to launch new products this year and beyond? Ph...
What are the major challenges that QBiotics is addressing through its research projects within Australia and globally? ...
Australia-based Vaxxas Pty Ltd, the biotechnology company pioneering the high-density microarray patch (HD-MAP) for need...
